Siegel R.L. Miller K.D. Fuchs H.E. et al.

Cancer statistics, 2022.

CA Cancer J Clin. 72: 7-33https://doi.org/10.3322/caac.21708Capitanio U. Bensalah K. Bex A. et al.

Epidemiology of Renal Cell Carcinoma.

Eur Urol. 75: 74-84https://doi.org/10.1016/j.eururo.2018.08.036Kaptein F.H.J. van der H.T. Braken S.J.E. et al.

Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma.

JACC CardioOncology. 4: 522-531https://doi.org/10.1016/j.jaccao.2022.07.011Blute M.L. Boorjian S.A. Leibovich B.C. et al.

Results of Inferior Vena Caval Interruption by Greenfield Filter, Ligation or Resection During Radical Nephrectomy and Tumor Thrombectomy.

J Urol. 178: 440-445https://doi.org/10.1016/j.juro.2007.03.121Beveridge T.S. Allman B.L. Johnson M. et al.

Considerations from a Cadaveric Study.

J Urol. 196: 1764-1771https://doi.org/10.1016/j.juro.2016.06.091Hostiuc S. Rusu M.C. Negoi I.

Dorobanțu B, Grigoriu M. Anatomical variants of renal veins: A meta-analysis of prevalence.

Sci Rep. 9: 10802https://doi.org/10.1038/s41598-019-47280-8Cesmebasi A. Du Plessis M. Iannatuono M. et al.

A review of the anatomy and clinical significance of adrenal veins.

Clin Anat. 27: 1253-1263https://doi.org/10.1002/ca.22374

Anatomy and classification - Mehran - 2000-Clinical Anatomy - Wiley Online Library.

() ()Loukas M. Louis R.G. Hullett J. et al.

An anatomical classification of the variations of the inferior phrenic vein.

Surg Radiol Anat. 27: 566-574https://doi.org/10.1007/s00276-005-0029-0Shchukin D. Lesovoy V. Garagatiy I. et al.

Surgical Approaches to Supradiaphragmatic Segment of IVC and Right Atrium through Abdominal Cavity during Intravenous Tumor Thrombus Removal.

Adv Urol. 2014: e924269https://doi.org/10.1155/2014/924269Singla N. Hutchinson R.C. Ghandour R.A. et al.

Improved survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in the contemporary immunotherapy era: An analysis of the National Cancer Database.

Urol Oncol Semin Orig Investig. 38: 604.e9https://doi.org/10.1016/j.urolonc.2020.02.029Bakouny Z. El Zarif T. Dudani S. et al.

Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.

Eur Urol. S0302-2838: 02713-02720Méjean A. Ravaud A. Thezenas S. et al.

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

N Engl J Med. 379: 417-427https://doi.org/10.1056/NEJMoa1803675Rathmell W.K. Rumble R.B. Van Veldhuizen P.J. et al.

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline.

J Clin Oncol. 40: 2957-2995https://doi.org/10.1200/JCO.22.00868Abel E.J. Spiess P.E. Margulis V. et al.

Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.

J Urol. 198: 281-288https://doi.org/10.1016/j.juro.2017.03.011Renal mass and localized renal cancer: evaluation, management, and follow up. American Urological Association, () ()Hallscheidt P.J. Fink C. Haferkamp A. et al.

Preoperative Staging of Renal Cell Carcinoma With Inferior Vena Cava Thrombus Using Multidetector CT and MRI: Prospective Study With Histopathological Correlation.

J Comput Assist Tomogr. 29: 64-68Lawrentschuk N. Gani J. Riordan R. et al.

Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review.

BJU Int. 96: 291-295https://doi.org/10.1111/j.1464-410X.2005.05617.xGuzzo T.J. Pierorazio P.M. Schaeffer E.M. et al.

The Accuracy of Multidetector Computerized Tomography for Evaluating Tumor Thrombus in Patients With Renal Cell Carcinoma.

J Urol. 181: 486-491https://doi.org/10.1016/j.juro.2008.10.040Kallman D.A. King B.F. Hattery R.R. et al.

Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma: CT, US, MRI and venacavography.

J Comput Assist Tomogr. 16: 240-247https://doi.org/10.1097/00004728-199203000-00012Davenport M.S. Perazella M.A. Yee J. et al.

Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.

Radiology. 294: 660-668https://doi.org/10.1148/radiol.2019192094

A hui, Hou X yan, Tian S, Zhang W fang. Diagnostic value of 18F-FDG PET/CT versus contrast-enhanced MRI for venous tumour thrombus and venous bland thrombus in renal cell carcinoma.

Sci Rep. 12: 587https://doi.org/10.1038/s41598-021-04541-9Alayed A. Krishna S. Breau R.H. et al.

Diagnostic Accuracy of MRI for Detecting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma Tumor Thrombus Using Quantitative and Subjective Analysis.

Am J Roentgenol. 212: 562-569https://doi.org/10.2214/AJR.18.20209Adams L.C. Ralla B. Bender Y.N.Y. et al.

Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI.

Cancer Imag. 18: 17https://doi.org/10.1186/s40644-018-0150-zWoolen S.A. Shankar P.R. Gagnier J.J. et al.

Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.

JAMA Intern Med. 180: 223-230https://doi.org/10.1001/jamainternmed.2019.5284Shi T. Huang Q. Liu K. et al.

Robot-assisted Cavectomy Versus Thrombectomy for Level II Inferior Vena Cava Thrombus: Decision-making Scheme and Multi-institutional Analysis.

Eur Urol. 78: 592-602https://doi.org/10.1016/j.eururo.2020.03.020Calderone C.E. Tuck B.C. Gray S.H. et al.

The role of transesophageal echocardiography in the management of renal cell carcinoma with venous tumor thrombus.

Echocardiography. 35: 2047-2055https://doi.org/10.1111/echo.14187Li Q.Y. Li N. Huang Q.B. et al.

Contrast-enhanced ultrasound in detecting wall invasion and differentiating bland from tumor thrombus during robot-assisted inferior vena cava thrombectomy for renal cell carcinoma.

Cancer Imag. 19: 79https://doi.org/10.1186/s40644-019-0265-xLi Q. Li N. Luo Y. et al.

Role of intraoperative ultrasound in robotic-assisted radical nephrectomy with inferior vena cava thrombectomy in renal cell carcinoma.

World J Urol. 38: 3191-3198https://doi.org/10.1007/s00345-020-03141-yAgarwal S. Mullikin D. Scheurer M.E. et al.

Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.

Pediatr Blood Cancer. 68: e29173https://doi.org/10.1002/pbc.29173Marcoux C. Al Ghamdi S. Manos D. et al.

Natural History of Tumor Thrombus: A Single-Centre Retrospective Study.

Blood. 134: 2430https://doi.org/10.1182/blood-2019-124476

Balzer -Haas Naomi. When Clot Is Tumor.

JACC CardioOncology. 4: 532-534https://doi.org/10.1016/j.jaccao.2022.10.005Pötzsch B. Klövekorn W.P. Madlener K.

Use of Heparin during Cardiopulmonary Bypass in Patients with a History of Heparin-Induced Thrombocytopenia.

N Engl J Med. 343: 515https://doi.org/10.1056/NEJM200008173430718Douketis J.D. Spyropoulos A.C. Murad M.H. et al.

Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.

Chest. 162: e207-e243https://doi.org/10.1016/j.chest.2022.07.025Smilowitz N.R. Berger J.S.

Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review.

JAMA. 324: 279-290https://doi.org/10.1001/jama.2020.7840Abel E.J. Wood C.G. Eickstaedt N. et al.

Preoperative Pulmonary Embolism Does Not Predict Poor Postoperative Outcomes in Patients with Renal Cell Carcinoma and Venous Thrombus.

J Urol. 190: 452-457https://doi.org/10.1016/j.juro.2013.02.033Saillant N.N. Kornblith L.Z. Moore H. et al.

The National Blood Shortage—An Impetus for Change.

Ann Surg. 275: 641-643https://doi.org/10.1097/SLA.0000000000005393Freifeld Y. Pedrosa I. Mclaughlin M. et al.

Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus.

Urol Oncol Semin Orig Investig. 40: 166.e9

Anesthesia for Nephrectomy with Vena Cava Thrombectomy.

in: Goudra B.G. Duggan M. Chidambaran V. Anesthesiology: a practical approach. Springer International Publishing, : 635-644Fukazawa K. Gologorsky E. Naguit K. et al.

Invasive Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus: Cardiac Anesthesia in Liver Transplant Settings.

J Cardiothorac Vasc Anesth. 28: 640-646https://doi.org/10.1053/j.jvca.2013.04.002Vinzant N.J. Christensen J.M. Smith M.M. et al.

Perioperative Outcomes for Radical Nephrectomy and Level III-IV Inferior Vena Cava Tumor Thrombectomy in Patients with Renal Cell Carcinoma.

J Cardiothorac Vasc Anesth. 36: 3093-3100https://doi.org/10.1053/j.jvca.2022.04.023Lardas M. Stewart F. Scrimgeour D. et al.

Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus.

Eur Urol. 70: 265-280https://doi.org/10.1016/j.eururo.2015.11.034Yagisawa T. Kondo T. Yoshida K. et al.

1911 usefulness of temporary inferior vena cava filter in preventing intraoperative pulmonary embolism for patients with renal cell carcinoma extending into inferior vena cava thrombus.

J Urol. 189: e783-e784https://doi.org/10.1016/j.juro.2013.02.2330Zhang J.P. Zhu Y. jun Liu Y. et al.

Temporary Filters and Liver Mobilization Technique Improve the Safety and Prognosis of Radical Nephrectomy and Inferior Vena Cava Thrombectomy in Renal Cell Carcinoma with Subdiaphragmatic Thrombosis.

Urol Int. 91: 279-284https://doi.org/10.1159/000350521Feng X. Bao J. Jing Z. et al.

Tempofilter II for tumor emboli prevention during radical nephrectomy and inferior vena cava thrombus resection for renal cell carcinoma.

J Surg Oncol. 100: 159-162https://doi.org/10.1002/jso.21303Shuch B. Larochelle J.C. Onyia T. et al.

Intraoperative Thrombus Embolization During Nephrectomy and Tumor Thrombectomy: Critical Analysis of the University of California-Los Angeles Experience.

J Urol. 181: 492-499https://doi.org/10.1016/j.juro.2008.10.036Kinnear N. O’Callaghan M. Hennessey D. et al.

Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies.

BJU Int. 123: 210-219https://doi.org/10.1111/bju.14373Iwata T. Kimura S. Foerster B. et al.

Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis.

Urol Oncol Semin Orig Investig. 37: 273-281https://doi.org/10.1016/j.urolonc.2019.01.018Blute M.L. Leibovich B.C. Lohse C.M. et al.

The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus.

BJU Int. 94: 33-41https://doi.org/10.1111/j.1464-410X.2004.04897.xGaudino M. Lau C. Cammertoni F. et al.

Surgical Treatment of Renal Cell Carcinoma With Cavoatrial Involvement: A Systematic Review of the Literature.

Ann Thorac Surg. 101: 1213-1221https://doi.org/10.1016/j.athoracsur.2015.10.003Faust W.C. D’Agostino R.S. Libertino J.

Comparative Effectiveness of Median Sternotomy vs Minimal Access Cardiopulmonary Bypass and Circulatory Arrest for Resection of Renal Cell Carcinoma with Inferior Vena Caval Extension.

J Cancer Ther. 7: 752-761https://doi.org/10.4236/jct.2016.710076Stecker M.M. Cheung A.T. Pochettino A. et al.

Deep hypothermic circulatory arrest: I. Effects of cooling on electroencephalogram and evoked potentials.

Ann Thorac Surg. 71: 14-21https://doi.org/10.1016/S0003-4975(00)01592-7Maclean W. Levy B. Rockall T.

Trauma laparotomy and damage control surgery.

Surg Oxf. 37: 549-557https://doi.org/10.1016/j.mpsur.2019.07.014Ciancio G. Vaidya A. Shirodkar S. et al.

En Bloc Mobilization of the Pancreas and Spleen to Facilitate Resection of Large Tumors, Primarily Renal and Adrenal, in the Left Upper Quadrant of the Abdomen: Techniques Derived from Multivisceral Transplantation.

Eur Urol. 55: 1106-1111https://doi.org/10.1016/j.eururo.2008.12.038

Application of Liver Transplant and Organ Procurement Techniques to Difficult Upper Abdominal Urological Cases.

J Urol. 151: 1652-1656Mattox K.L. Mccollum W.B. Jordan G.L. et al.

Management of upper abdominal vascular trauma.

Am J Surg. 128: 823-828https://doi.org/10.1016/0002-9610(74)90079-8

“Thrombus-first” or “thrombus-last” approach for surgical management of renal cell carcinoma with inferior vena cava thrombus - Ishiyama - 2022-International Journal of Urology - Wiley Online Library.

() ()Xie L. Hong G. Nabavizadeh R. et al.

Outcomes in Patients with Renal Cell Carcinoma Undergoing Inferior Vena Cava Ligation without Reconstruction versus Thrombectomy: A Retrospective, Case Controlled Study.

J Urol. 205: 383-391https://doi.org/10.1097/JU.0000000000001354Olmez A. Karabulut K. Aydin C. et al.

Comparison of Harmonic Scalpel Versus Conventional Knot Tying for Transection of Short Hepatic Veins at Liver Transplantation: Prospective Randomized Study.

Transplant Proc. 44: 1717-1719https://doi.org/10.1016/j.transproceed.2012.05.035Garg H. Kaushik D. Hui D. et al.

Haemodynamic changes during radical nephrectomy with inferior vena cava thrombectomy: A pilot study.

BJUI Compass. 3: 327-330https://doi.org/10.1002/bco2.154Tzakis A. Todo S. Starzl T.E.

Orthotopic liver transplantation with preservation of the inferior vena cava.

Ann Surg. 210: 649-652

Close relation between the inferior vena cava ligament and the caudate lobe in the human liver - Kogure - 2007-Journal of Hepato-Biliary-Pancreatic Surgery - Wiley Online Library.

() ()

V13-07 inferior vena cava management during left-sided level iii tumor thrombectomy.

J Urol. 207: e1033https://doi.org/10.1097/JU.0000000000002646.07Simon R.M. Kim T. Espiritu P. et al.

Effect of utilization of veno-venous bypass vs. cardiopulmonary bypass on complications for high level inferior vena cava tumor thrombectomy and concomitant radical nephrectomy.

Int Braz J Urol. 41: 911-919

The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus - Blute - 2004-BJU International - Wiley Online Library.

() ()Jibiki M. Iwai T. Inoue Y. et al.

Surgical strategy for treating renal cell carcinoma with thrombus extending into the inferior vena cava.

J Vasc Surg. 39: 829-835https://doi.org/10.1016/j.jvs.2003.12.004

V11-06 the open abdominal approach to level iii/iv vena caval tumor thrombi with caval obstruction.

J Urol. 206: e859https://doi.org/10.1097/JU.0000000000002073.06Patil M.B. Montez J. Loh-Doyle J. et al.

Level III-IV Inferior Vena Caval Thrombectomy Without Cardiopulmonary Bypass: Long-Term Experience with Intrapericardial Control.

J Urol. 192: 682-689https://doi.org/10.1016/j.juro.2014.03.112Garg H. Psutka S.P. Hakimi A.A. et al.

A Decade of Robotic-Assisted Radical Nephrectomy with Inferior Vena Cava Thrombectomy: A Systematic Review and Meta-Analysis of Perioperative Outcomes.

J Urol. 208: 542-560https://doi.org/10.1097/JU.0000000000002829Enezate T. Alkhatib D. Raja J. et al.

AngioVac for Minimally Invasive Removal of Intravascular and Intracardiac Masses: a Systematic Review.

Curr Cardiol Rep. 24: 377-382https://doi.org/10.1007/s11886-022-01658-9Moriarty J.M. Rueda V. Liao M. et al.

Endovascular Removal of Thrombus and Right Heart Masses Using the AngioVac System: Results of 234 Patients from the Prospective, Multicenter Registry of AngioVac Procedures in Detail (RAPID).

J Vasc Interv Radiol. 32 (): 549-557

Inferior vena cava-syndrome | Vasa.

() ()Rose K.M. Huelster H.L. Roberts E.C. et al.

Contemporary Management of Chylous Ascites after Retroperitoneal Surgery: Development of an Evidence-Based Treatment Algorithm.

J Urol. 208: 53-61https://doi.org/10.1097/JU.0000000000002494

Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial). clinicaltrials.gov; 2022.

() ()

Multicenter Randomized Trial of Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma Receiving Checkpoint Inhibitors: A DaRenCa and NoRenCa Trial Evaluating the Impact of Surgery or No Surgery. NORDIC-SUN-Trial. clinicaltrials.gov.

() ()Runcie K. Singer E.A. Ornstein M.C. et al.

Cyto-KIK: A phase II trial of cytoreductive surgery in kidney cancer plus immunotherapy (nivolumab) and targeted kinase inhibition (cabozantinib).

J Clin Oncol. 39: TPS4598Pignot G. Thiery-Vuillemin A. Albigès L. et al.

Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.

Eur Urol Oncol. 5: 577-584https://doi.org/10.1016/j.euo.2022.07.002Unadkat P. Olumi A.F. Gershman B.

The Role of Lymphadenectomy in Patients with Advanced Renal Cell Carcinoma.

Urol Clin North Am. 47: 371-377https://doi.org/10.1016/j.ucl.2020.04.001Wang B. Huang Q. Liu K. et al.

Robot-assisted Level III-IV Inferior Vena Cava Thrombectomy: Initial Series with Step-by-step Procedures and 1-yr Outcomes.

Eur Urol. 78: 77-86https://doi.org/10.1016/j.eururo.2019.04.019Motzer R.J. Tannir N.M. McDermott D.F. et al.

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

N Engl J Med. 378: 1277-1290https://doi.org/10.1056/NEJMoa1712126Motzer R. Alekseev B. Rha S.Y. et al.

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.

N Engl J Med. 384: 1289-1300https://doi.org/10.1056/NEJMoa2035716Choueiri T.K. Powles T. Burotto M. et al.

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

N Engl J Med. 384: 829-841https://doi.org/10.1056/NEJMoa2026982Labbate C. Hatogai K. Werntz R. et al.

Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy.

J Immunother Cancer. 7: 66https://doi.org/10.1186/s40425-019-0546-8Albiges L. Tannir N.M. Burotto M. et al.

First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial.

Eur Urol. 81: 266-271https://doi.org/10.1016/j.eururo.2021.10.001Stewart G.D. Welsh S.J. Ursprung S. et al.

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA).

Br J Cancer. 127: 1051-1060https://doi.org/10.1038/s41416-022-01883-7Choueiri T.K. Tomczak P. Park S.H. et al.

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.

N Engl J Med. 385: 683-694https://doi.org/10.1056/NEJMoa2106391Powles T. Tomczak P. Park S.H. et al.

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet Oncol. 23: 1133-1144https://doi.org/10.1016/S1470-2045(22)00487-9Pal S.K. Uzzo R. Karam J.A. et al.

Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial.

Lancet Lond Engl. 400: 1103-1116https://doi.org/10.1016/S0140-6736(22)01658-0

Bristol Myers Squibb Provides Update on CheckMate -914 Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) as Adjuvant Treatment of Localized Renal Cell Carcinoma.

() ()Choueiri T.K. Bedke J. Karam J.A. et al.

LITESPARK-022: A phase 3 study of pembrolizumab + belzutifan as adjuvant treatment of clear cell renal cell carcinoma (ccRCC).

J Clin Oncol. 40: TPS4602Haddad A.Q. Wood C.G. Abel E.J. et al.

Oncologic Outcomes Following Surgical Resection of Renal Cell Carcinoma with Inferior Vena Caval Thrombus Extending Above the Hepatic Veins: A Contemporary Multicenter Cohort.

Journal of Urology. 192: 1050-1056